Drugs / Budesonide/formoterol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02308098 | Dec 2014 → Jun 2015 | asthma | Orion Corporation, Orion Pharma | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide/formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02308098 ↗ |
| Known as | Budesonide/Formoterol Easyhaler | “Therapeutic equivalence of Budesonide/formoterol Easyhaler compared to Symbicort Turbuhaler has been previously demonstrated with in vitro and pharmacokinetic studies.” PMID 27817813 ↗ Sep 2016 |
| Route | Inhaled | “320/9 μg and 1280/36 μg of budesonide/formoterol delivered by Easyhaler and Turbuhaler” PMID 27817813 ↗ Sep 2016 |